Sarepta Therapeutics, which develops precision genetic medicines for DMD, trades on the Nasdaq and is headquartered in Cambridge.
4 reports, 3 independent
Updated Oct 21
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sarepta Therapeutics, which develops precision genetic medicines for DMD, trades on the Nasdaq and is headquartered in Cambridge.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sarepta Therapeutics
biopharmaceutical company
-
Nasdaq
American fully electronic stock exchange
-
DMD
Nothing else this week.
Related events
- BioNano Genomics traded on the Nasdaq stock exchange on July 9, 2026.
- BR Biopharma began trading on the Nasdaq exchange on November 10, 2026.
- Immunic, Inc. has been trading on the Nasdaq stock exchange since August 1, 2026.
- Mentari Therapeutics, Inc. was listed on the Nasdaq stock exchange on November 4, 2026.
- Praxis Precision Medicines and Relay Therapeutics were listed on the Nasdaq stock exchange on October 1, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- tickerreport.com
- themarketsdaily.com
- dailypolitical.comAnalysts’ Weekly Ratings Changes for Sarepta Therapeutics (SRPT)